TP53 and central nervous system cancer: The Abounader research team, for the first time, studied the role of miR-34a in brain tumors with a focus on gliomas (Li et al., 2009) and found that miR-34a expression was reduced in human gliomas and that miR-34a levels in p53-mutant gliomas were lower than in p53 wild-type tumors.